» Articles » PMID: 31154308

Associations of Serum Liver Enzyme Levels and Their Changes over Time with All-cause and Cause-specific Mortality in the General Population: a Large-scale National Health Screening Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Jun 3
PMID 31154308
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the associations of the levels of liver enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyltransferase (GGT), at baseline and their changes over time with mortality.

Design: Cohort study.

Setting, Participants And Outcome Measures: We analysed the data of 484 472 individuals from the National Health Insurance Service-National Health Screening Cohort (2002-2013). We used two exposure indices: (1) deciles of baseline ALT, AST and GGT levels measured in 2002 or 2003 and (2) deciles of changes in ALT, AST and GGT levels over a 4 year period (2002-2006 or 2003-2007). We constructed Cox models to evaluate the associations of these exposure indices with mortality (2008-2013).

Results: We found non-monotonic dose-response associations between the baseline levels of ALT and AST and all-cause mortality. We also found a monotonic non-linear association between the baseline levels of GGT and all-cause mortality (10th decile: HR=2.05, 95% CI: 1.93 to 2.18). Compared with the ninth, sixth and fourth deciles of changes in ALT (8-13 U/L), AST (1 U/L) and GGT (-3 to -2 U/L) over time, respectively, the risks of all-cause mortality increased in both the higher and lower deciles of changes in the corresponding liver enzyme levels (10th decile: HR=1.36, 95% CI 1.24 to 1.48; 1st decile: HR=1.46, 95% CI 1.34 to 1.59 for ALT; 10th decile: 1.55, 95% CI 1.40 to 1.71; 1st decile: HR=1.53, 95% CI 1.38 to 1.69 for AST; 10th decile: HR=1.71, 95% CI 1.56 to 1.88; 1st decile: HR=1.67, 95% CI 1.52 to 1.84 for GGT). These non-monotonic dose-response associations remained when analyses were stratified by the medians or quartiles of the baseline liver enzyme levels.

Conclusions: The levels of liver enzymes at baseline and over time showed non-linear associations with mortality.

Citing Articles

Elucidating the role of liver enzymes as markers and regulators in ovarian cancer: a synergistic approach using Mendelian randomization, single-cell analysis, and clinical evidence.

Zhu Y, Jiang M, Gu Z, Shang H, Tang C, Guo T Hum Genomics. 2024; 18(1):71.

PMID: 38915066 PMC: 11197171. DOI: 10.1186/s40246-024-00642-4.


Natural products and dietary interventions on liver enzymes: an umbrella review and evidence map.

Li Z, Wu J, Zhao Y, Song J, Wen Y Front Nutr. 2024; 11:1300860.

PMID: 38371505 PMC: 10869519. DOI: 10.3389/fnut.2024.1300860.


Independent and additive effects of binge drinking and obesity on liver enzymes: a cross-sectional analysis using the Korean National Health Insurance Service data.

Kityo A, Lee S Gastroenterol Rep (Oxf). 2024; 12:goad074.

PMID: 38222462 PMC: 10784631. DOI: 10.1093/gastro/goad074.


Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non-small cell lung cancer after a single 200 mg administration.

de Vries F, Smit A, Wolbink G, de Vries A, Loeff F, Franssen E Front Oncol. 2023; 12:960116.

PMID: 36713570 PMC: 9875126. DOI: 10.3389/fonc.2022.960116.


Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs.

Galatou E, Mourelatou E, Hatziantoniou S, Vizirianakis I Antioxidants (Basel). 2022; 11(6).

PMID: 35739957 PMC: 9220192. DOI: 10.3390/antiox11061060.


References
1.
Liu Z, Ning H, Que S, Wang L, Qin X, Peng T . Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies. PLoS One. 2014; 9(3):e91410. PMC: 3954728. DOI: 10.1371/journal.pone.0091410. View

2.
Dignam J, Zhang Q, Kocherginsky M . The use and interpretation of competing risks regression models. Clin Cancer Res. 2012; 18(8):2301-8. PMC: 3328633. DOI: 10.1158/1078-0432.CCR-11-2097. View

3.
Targher G, Byrne C, Lonardo A, Zoppini G, Barbui C . Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016; 65(3):589-600. DOI: 10.1016/j.jhep.2016.05.013. View

4.
Williams K, Sullivan D, Nicholson G, George J, Jenkins A, Januszewski A . Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism. 2016; 65(5):783-793. DOI: 10.1016/j.metabol.2015.12.008. View

5.
Deetman P, Alkhalaf A, Landman G, Groenier K, Kootstra-Ros J, Navis G . Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38). Eur J Clin Invest. 2015; 45(8):807-14. DOI: 10.1111/eci.12474. View